Andrea Briggs has over 30 years of experience in all aspects of the pharmaceutical industry – development, technical transfers, regulatory support, inspection management/remediation, quality control and quality assurance practices in R&D, clinical, and commercial environments. In her current role, Andrea has overall responsibility for compliance at the Cell and Gene Therapy CDMO sites at Charles River Laboratories. Prior to joining the organization, Andrea served as Director of Quality for Cell and Gene Therapy with Thermo Fisher Scientific where she developed/implemented phase appropriate quality systems in addition to developing the quality department for the business unit. During her career, she has presented on relevant topics such as data integrity and phase appropriate quality oversight. Andrea holds a Bachelor of Science from Central Michigan University in Chemistry and is also an ASQ Certified Six Sigma Black Belt, Certified Quality Auditor, and Certified Quality Engineer.
Andrea Briggs
Senior Director, Global Cell and Gene Therapy Compliance